TIDMKNB
RNS Number : 6124Z
Kanabo Group PLC
15 January 2024
15 January 2024
Kanabo Group Plc
("Kanabo", the "Group" or the "Company")
Partnership with City Dock Pharmacy to launch a Walk-In Pain
Clinic
UK's first walk-in clinic for pain management delivering
specialised medicine, including medicinal cannabis
Kanabo Group plc (LSE: KNB), the patient-focused provider of
digital health services and specialist medicines, including
medicinal cannabis, is pleased to announce it has signed a
partnership with City Dock Pharmacy in London, to launch a walk-in
pain clinic offering specialised medicines, including medicinal
cannabis, which is the first of its kind.
The pain clinic, which will be based at City Dock Pharmacy in
Wapping, London, will offer both appointment-based and walk-in
services. The clinic will leverage Kanabo's Treat It online
platform, and pharmacists will be on hand to guide patients through
the medicinal cannabis treatment options. Furthermore, the clinic
supports the delivery of personalised treatment plans for the
growing number of chronic pain sufferers in the UK, who often face
difficulties accessing medical treatments due to long waiting
times, bureaucracy and affordability.
The partnership with City Dock Pharmacy will combine Kanabo's
expertise in medicinal cannabis with traditional treatments for
pain management and will cater for patients who are eligible for
alternative therapies, as traditional treatments have not delivered
improvements. The partnership with City Dock Pharmacy should result
in an increase of patients who receive treatment through Kanabo's
Treat It platform.
The launch of the walk-in pain clinic with City Dock Pharmacy
represents progress against the Group's strategy, as announced on
29 September 2023, to extend its reach into physical pharmacies
across the UK offering Kanabo's services to patients. The Company
will seek to replicate this model across more pharmacies,
leveraging the extensive pharmacy network partnership in Kanabo's
digital health division.
Avihu Tamir, Chief Executive Officer of Kanabo, commented:
"This collaboration is a testament to our dedication to
innovating in pain management. The combination of City Dock
Pharmacy's trusted presence and our expertise in medicinal cannabis
paves the way for a new, holistic approach to treating pain and the
opportunity to extend this to additional indications."
Enquiries:
via Vigo Consulting
Kanabo Group plc +44 (0)20 7390 0230
Avihu Tamir, Chief Executive Officer
Assaf Vardimon, Chief Financial Officer
Ian Mattioli, Non-Executive Chair of the Board
Peterhouse Capital Limited (Financial Adviser
and Broker)
Eran Zucker / Lucy Williams / Charles Goodfellow +44 (0)20 7469 0930
Vigo Consulting (Financial Public Relations/Investor
Relations)
Jeremy Garcia / Fiona Hetherington / Verity
Snow +44 (0)20 7390
kanabo@vigoconsulting.com 0230
About Kanabo Group plc
Kanabo Group plc (LSE:KNB) is a digital health company committed
to transforming patient care through its innovative technology
platform and specialised treatment offerings. Since its inception
in 2017, Kanabo has been focused on researching, developing, and
commercialising regulated medicinal cannabis-derived formulations
and therapeutic inhalation devices.
Kanabo's NHS-approved online telehealth platform, The GP
Service, provides patients with video consultations, online
prescriptions, and primary care services. Leveraging its telehealth
capabilities, in February 2023, Kanabo launched Treat It - an
online clinic focused on chronic pain management providing patients
with secondary care.
With its two complementary business divisions, Kanabo has
established itself as an end-to-end digital health provider,
offering telehealth consultations, prescriptions, alongside the
delivery of tailored treatments.
The Company's partially owned subsidiary, Kanabo Agritec Ltd, is
a cultivation consultancy supporting cannabis businesses in
developing new farms through infrastructural, research, and product
guidance. These farms deliver high-quality raw materials for
Kanabo's formulas and product line.
At Kanabo Group Plc, we are dedicated to providing patients with
the highest quality medical treatments and more accessible
healthcare experiences.
Visit www.kanabogroup.com for more information.
About City Dock Pharmacy
City Dock Pharmacy, based in Wapping, London, is at the cutting
edge of innovative healthcare. This patient-focused team bridges
the gap between traditional and modern medical treatments, serving
both NHS and private patients with advanced healthcare
technologies.
The pharmacy has an in-house beauty clinic offering various
services such as facials, anti-wrinkle injections, Platelet Rich
Plasma (PRP) therapy and dermal fillers.
Complementing these offerings is a Pain Management Clinic, which
provides expert advice on medical cannabis and various herbal
medications, showcasing its comprehensive approach to health and
wellness.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCEAPFLFFFLEFA
(END) Dow Jones Newswires
January 15, 2024 02:00 ET (07:00 GMT)
Kanabo (LSE:KNB)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Kanabo (LSE:KNB)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024
